Menin drugs for Acute Lymphoblastic Leukemia
2 tracked Menin drugs in the Acute Lymphoblastic Leukemia race. The class explanation lives on the Menin page; the full indication pipeline across every mechanism is on the Acute Lymphoblastic Leukemia page.
1 approved / phase 41 Phase 1/2
Head-to-head evidence: Revumenib vs Ziftomenib